Mass Spectrometry Imaging Market Expected to Grow at 9% CAGR Through 2029: Industry Forecast

Mass Spectrometry Imaging Market

 Unlock 20% Off Global Market Reports Using Code ONLINE20 – Stay Informed on Trade Policies, Market Growth, and Key Disruptors

How Strong Is the Market Growth Outlook for the Mass Spectrometry Imaging Market?

The mass spectrometry imaging market size has grown strongly in recent years. It will grow from $2.65 billion in 2024 to $2.88 billion in 2025 at a compound annual growth rate (CAGR) of 8.8%. The growth in the historic period can be attributed to increasing adoption in pharmaceutical research, rising demand for personalized medicine, rise in cancer diagnostics applications, increase in drug discovery and development activities, and increasing funding for biomedical research.

The mass spectrometry imaging market size is expected to see strong growth in the next few years. It will grow to $4.07 billion in 2029 at a compound annual growth rate (CAGR) of 9.0%. The growth in the forecast period can be attributed to a growing focus on spatial omics research, an increasing use in biomarker discovery, a rising integration with artificial intelligence tools, expanding applications in clinical diagnostics, and an increase in demand for high-resolution imaging techniques. Major trends in the forecast period include advancement in high-resolution mass spectrometry technologies, advanced imaging software integration, innovation in sample preparation techniques, advancement in hybrid imaging modalities, and advanced automation in data analysis workflows.

Claim your free report sample now:

Which Major Growth Drivers Will Influence the Mass Spectrometry Imaging Market by 2029?

The rising demand for personalized medicine is expected to propel the growth of the mass spectrometry imaging market going forward. Personalized medicine customizes healthcare treatments to each patient, considering their genetic makeup, environment, and lifestyle to improve effectiveness. The rise of personalized medicine is driven by genomic advancements, enabling targeted treatments based on genetic profiles, which enhance effectiveness and reduce side effects. Mass spectrometry imaging supports personalized medicine by creating detailed molecular maps of tissues, helping identify disease biomarkers, and enabling the development of targeted therapies tailored to individual patient profiles. For instance, in February 2024, according to the Personalized Medicine Coalition, a US-based non-profit organization, in 2023 the FDA approved 16 new personalized treatments for patients with rare diseases, a significant increase from the six approved in 2022. Therefore, the rising demand for personalized medicine is driving the growth of the mass spectrometry imaging market.

How Is the Mass Spectrometry Imaging Market Segmented?

The mass spectrometry imaging market covered in this report is segmented –

1) By Product Type: Instruments, Consumables, Services

2) By Technology: Matrix-Assisted Laser Desorption Or Ionization (MALDI), Secondary Ion Mass Spectrometry (SIMS), Desorption Electrospray Ionization (DESI), Magnetic Sector Mass Spectrometry, Time-of-Flight Mass Spectrometry (TOFMS), Other Technologies

3) By Application: Proteomics, Metabolomics, Glycomics, Other Applications

4) By End-User: Pharmaceutical and Biotechnology Companies, Government and Academic Institutions, Other End-Users

Subsegments:

1) By Instruments: High-Resolution Mass Spectrometers, Imaging Mass Spectrometers, Matrix-Assisted Laser Desorption Or Ionization Time-of-Flight System, Liquid Chromatography-Mass Spectrometry System, Quadrupole Time-of-Flight Mass Spectrometers, Tandem Mass Spectrometers

2) By Consumables: Reagents And Chemicals, Sample Preparation Kits, Mass Spectrometry Plates And Slides, Calibration Standards, Solvents And Buffers

3) By Services: Installation And Maintenance Services, Data Analysis And Software Services, Training And Support Services, Consultation And Customization Services

Which Trends Are Positively Affecting the Mass Spectrometry Imaging Market Expansion?

Major companies operating in the mass spectrometry imaging (MSI) market are focused on developing advanced technology, such as desorption electrospray ionization, to enable more accurate and detailed molecular analysis for a wide range of applications. Desorption electrospray ionization (DESI) is an ionization method that extracts ions from surfaces in ambient conditions using a charged solvent spray. It enables direct analysis of solid samples, such as tissues, without the need for sample preparation or extraction. For instance, in June 2023, Waters Corporation, a US-based analytical laboratory instrument manufacturing company, launched a targeted imaging mass spectrometer. It enhances tissue analysis with improved sensitivity and speed. The instrument provides more precise small-molecule drug analysis, offering higher resolution in targeted imaging. It enables faster detection, streamlining biological studies. The device boosts accuracy and efficiency, significantly benefiting research processes. This innovation supports advanced drug development and biological research by providing detailed, high-quality data.

Which Organizations Are Key Contributors to the Mass Spectrometry Imaging Market?

Major companies operating in the mass spectrometry imaging market are Thermo Fisher Scientific Inc., Danaher Corporation, Hitachi High-Tech Corporation, Shimadzu Corporation, Waters Corporation, Bruker Corporation, Horiba Scientific, JEOL Ltd., SCIEX, Analytik Jena AG, Standard BioTools, TOFWERK AG, Advion Inc., MassTech Inc., CovalX AG, ImaBiotech SAS, MassAnalytica LLC, Ionwerks Inc., Biognosys AG, Spectroswiss Sàrl

Get the full mass spectrometry imaging market report here:

What Are the Regional Market Share Projections for the Mass Spectrometry Imaging Market?

North America was the largest region in the mass spectrometry imaging market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the mass spectrometry imaging market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Contact Us:

The Business Research Company

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email: info@tbrc.info

Follow Us On:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

Comments